Literature DB >> 22192476

HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts.

Venkataswarup Tiriveedhi1, Andrew E Gelman, T Mohanakumar.   

Abstract

Long term survival of the human lung allografts are hindered by chronic rejection, manifested clinically as bronchiolitis obliterans syndrome (BOS). We previously demonstrated significant correlation between the development of antibodies (Abs) to K-α1-tubulin (Kα1T) and BOS. In this study, we investigated the molecular basis for fibrinogenesis mediated by ligation of Kα1T expressed on airway epithelial cells by its specific Abs. Using RT-PCR we demonstrate that normal human bronchial epithelial (NHBE) cells upon ligation of Kα1T with specific Abs caused upregulation of pro-fibrotic growth factors. Western blot analysis of NHBE incubated with Kα1T Abs increased hypoxia inducible factor (HIF-1α). Kα1T Ab-mediated growth factor expression is dependent on HIF-1α as inhibition of HIF-1α returned fibrotic growth factor expression to basal levels. In conclusion, we propose that HIF-1α -mediated upregulation of fibrogenic growth factors induced by ligation of Kα1T Abs is critical for development of fibrosis leading to chronic rejection of lung allograft.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192476      PMCID: PMC3264699          DOI: 10.1016/j.cellimm.2011.11.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  49 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2008-09       Impact factor: 10.247

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine.

Authors:  Andrew J Leger; Allison Altobelli; Leocadia M Mosquea; Adam J Belanger; Antonius Song; Seng H Cheng; Canwen Jiang; Nelson S Yew
Journal:  J Bone Miner Metab       Date:  2010-03-19       Impact factor: 2.626

5.  Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome.

Authors:  A Jaramillo; B Naziruddin; L Zhang; S I Reznik; M A Smith; A A Aloush; E P Trulock; G A Patterson; T Mohanakumar
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

6.  De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Authors:  Trudie A Goers; Sabarinathan Ramachandran; Aviva Aloush; Elbert Trulock; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.

Authors:  M DeNiro; O Alsmadi; F Al-Mohanna
Journal:  Exp Eye Res       Date:  2009-07-04       Impact factor: 3.467

8.  Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis.

Authors:  Carole Peyssonnaux; Pilar Cejudo-Martin; Andrew Doedens; Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 9.  Growth factors in lung development and disease: friends or foe?

Authors:  Tushar J Desai; Wellington V Cardoso
Journal:  Respir Res       Date:  2001-10-09

10.  Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression.

Authors:  J Boesiger; M Tsai; M Maurer; M Yamaguchi; L F Brown; K P Claffey; H F Dvorak; S J Galli
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  23 in total

1.  Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.

Authors:  Muthukumar Gunasekaran; Monal Sharma; Ramsey Hachem; Ross Bremner; Michael A Smith; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

2.  Potential anticancer effect of prostratin through SIK3 inhibition.

Authors:  Dalal Alotaibi; Suneetha Amara; Terrance L Johnson; Venkataswarup Tiriveedhi
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

3.  T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.

Authors:  V Tiriveedhi; M Takenaka; S Ramachandran; A E Gelman; V Subramanian; G A Patterson; T Mohanakumar
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

4.  Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells.

Authors:  Suneetha Amara; Mu Zheng; Venkataswarup Tiriveedhi
Journal:  Cell Biochem Biophys       Date:  2016-05-28       Impact factor: 2.194

5.  Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.

Authors:  Venkataswarup Tiriveedhi; Natalia Tucker; John Herndon; Lijin Li; Mark Sturmoski; Matthew Ellis; Cynthia Ma; Michael Naughton; A Craig Lockhart; Feng Gao; Timothy Fleming; Peter Goedegebuure; Thalachallour Mohanakumar; William E Gillanders
Journal:  Clin Cancer Res       Date:  2014-12-01       Impact factor: 12.531

Review 6.  Clinical relevance of lung-restricted antibodies in lung transplantation.

Authors:  Mahzad Akbarpour; Qiang Wu; Xianpeng Liu; Haiying Sun; Emilia Lecuona; Rade Tomic; Sangeeta Bhorade; Thalachallour Mohanakumar; Ankit Bharat
Journal:  Hum Immunol       Date:  2019-05-08       Impact factor: 2.850

7.  Role of alloimmunity and autoimmunity in allograft rejection.

Authors:  Babak Banan; Zhongping Xu; Muthukumar Gunasekaran; T Mohanakumar
Journal:  Clin Transpl       Date:  2013

8.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Authors:  Vera Ivanova; Olga B Garbuzenko; Kenneth R Reuhl; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Eur J Pharm Biopharm       Date:  2012-12-08       Impact factor: 5.571

Review 9.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

Review 10.  Moving beyond HLA: a review of nHLA antibodies in organ transplantation.

Authors:  Tara K Sigdel; Minnie M Sarwal
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.